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Background: To identify the prevalence and clinicopathological profile of calcifying odontogenic cysts (COC) 
stored at an oral pathology service, and to analyze the immunoexpression of cyclooxygenase 2 (COX-2) and cyclin 
D1 (CD1) in these cysts. 
Material and Methods: After a retrospective analysis (1990-2016) carried out to identify cases of COC, a sample of 
12 cases was selected for immunohistochemical analysis of COX-2 and CD1 by the immunoperoxidase technique. 
Protein expression was evaluated semiquantitatively by attributing a score of 0 to 3 (0 = no staining; 1 = 1-25%; 2 
= 26-50%, and 3 = >51% immunopositive cells).
Results: Twenty cases of COC were diagnosed over the study period. These cysts were more common in the pos-
terior mandible and in men (male-to-female ratio of 1.2:1), with a mean age of 29.9 years. Among the 12 cases 
analyzed, immunoexpression of COX-2 was observed only in the inflammatory infiltrate in 50% of the cysts (n = 
6). Protein CD1 was detected (score 1) in 66.6% of cases (n = 8), and COX-2 was negative in 50% (n = 6).
Conclusions: The prevalence of COC among all odontogenic cysts was 3.5%, representing an uncommon lesion. 
Immunohistochemical analysis suggested that COX-2 does not participate in lesion progression. The cell prolifera-
tion index of COC was low, as demonstrated by the expression of CD1, suggesting a proliferative profile compati-
ble with more indolent lesions.
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Introduction
Calcifying odontogenic cysts (COC) were described 
for the first time by Rywkind in 1932, but in 1962 Gor-
lin (1) defined them as an entity pathologically distinct 
from calcifying odontogenic tumors and characterized 
them as non-neoplastic cystic lesions. However, in 1981, 
Praetorius et al. (2) proposed a new classification and 
revised the biological potential of this lesion. In 2005, 
the World Health Organization (WHO) defined COC as 
a benign cystic tumor arising from odontogenic epithe-
lium with ectomesenchyme, which can be associated or 
not with the formation of hard tissue. COC was there-
fore renamed calcifying cystic odontogenic tumor (3). 
In 2017, the WHO reclassified this lesion as COC and 
included it in the group of odontogenic and non-odonto-
genic developmental cysts (4).
Calcifying odontogenic cysts are uncommon lesions of 
variable clinical behavior that account for approximate-
ly 0.3% of all lesions diagnosed in oral pathology labo-
ratories and for 1 to 7% of odontogenic cysts and tumors 
(5-7). Thus, knowledge of the biological behavior of 
lesions affecting the oral cavity, including these cysts, 
is essential for an adequate therapeutic approach and to 
establish the prognosis for each case.
The evaluation of cell proliferation can be used as a po-
tential indicator of behavior, treatment response, and 
recurrence (8). Furthermore, the study of the cell cycle 
in odontogenic cysts and tumors is important since this 
is an organized and complex process (7,9). Within this 
context, cyclin D1 (CD1) is one of the proteins involved 
in the transition from the G1 to the S phase of the cell 
cycle in both normal and neoplastic cells. Overexpres-
sion of CD1 alters the cell cycle, causing uncontrolled 
proliferation and transformation to a neoplastic pheno-
type (10).
In addition to the study of cell proliferation, the analy-
sis of protein expression of cyclooxygenases (COX) in 
COC can provide information and help establish treat-
ment strategies since the inflammatory response is re-
cognized as one of the first events in tumorigenesis. In 
this respect, recent studies have demonstrated the par-
ticipation of COXs in tumor development. COXs are 
enzymatic mediators of the inflammatory process and 
are responsible for the conversion of arachidonic acid 
to prostaglandins and thromboxane. This enzyme is ex-
pressed in a limited number of cells and is induced by 
growth factors and tumorigenic stimuli. Overexpression 
of COX-2 is related to angiogenesis and cell prolifera-
tion (11-13).
To better understand the interaction between cells and 
biological markers, the objective of this study was to 
identify the prevalence and clinicopathological profile 
of COC, and to analyze the immunohistochemical ex-
pression of COX-2 and CD1.
Material and Methods
-Study design, ethical approval and sample
The study was approved by the local Research Ethics 
Committee (Approval No. 43364215.0.0000.5207). A 
retrospective study was conducted to identify cases of 
COC registered at a public oral pathology service in nor-
theastern Brazil between 1990 and 2016. The patient’s 
identity remained anonymous according to the Declara-
tion of Helsinki.
The sample originated from incisional (n = 9) and exci-
sional (n = 11) biopsies. The clinical data and demogra-
phic characteristics were: anatomical site, age at diag-
nosis, gender, symptomatology, lesion size (determined 
according to the largest diameter), and radiological as-
pects were collected from the patients’ medical records.
-Inclusion and exclusion criteria
All included COC cases were classified according the 
latest edition of the WHO classification (4) as follows: 
cyst wall: lined with thin ameloblastomatous epithelium; 
presence of ghost cells: calcified or not; epithelium in 
adjacent connective tissue: proliferative or not; dysplas-
tic dentin: present or absent. The cases were analyzed 
by two independent oral and maxillofacial pathologists 
with more than 20 years of experience. Records without 
accurate information regarding the histopathological 
diagnosis were excluded. For immunohistochemical 
analysis, cases were excluded if there was insufficient 
material for analysis.
-Immunohistochemistry
For immunohistochemistry, 3-µm thick tissue sections 
were mounted on organosilane-coated slides. The sec-
tions were deparaffinized, rehydrated and immersed in 
3% hydrogen peroxide. For antigen retrieval, the sec-
tions were heated in 10 mM sodium citrate buffer, pH 
6.0, in an electrical pressure cooker (approximately 103 
kPa, 120º C, 3 min). The primary antibodies against 
COX-2 (clone SP21; Spring, Pleasanton, CA, USA, di-
luted in BSA 1:200) and CD1 (clone P2D11F11; Novo-
castra, Rockford, IL, USA, diluted in BSA 1:50), then 
the sections were incubated for 60 min at 4º C. The reac-
tion was amplified with the streptavidin-biotin complex 
and diaminobenzidine was used as a chromogen for co-
lor development. The sections were counterstained with 
Mayer’s hematoxylin and cover slipped.
Sections of human breast carcinoma were used as posi-
tive controls for the anti-COX-2 antibody, and sections 
of human fetal lung tissue were used for the anti-CD1 
antibody. Negative controls were samples treated as des-
cribed previously, except that the primary antibody was 
omitted and replaced with non-immune murine IgG1 
(X-0931, DAKO) or 1% BSA-PBS for both antibodies 
studied.
-Evaluation of immunostaining
Immunostaining was analyzed under a light microsco-
pe (Nikon Eclipse-E200, Tokyo, Japan) by two oral and 
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maxillofacial pathologists considering the following pa-
rameters: type of immunopositive cells and localization 
(membrane or cytoplasm and nucleus). The observation 
of a brown color was defined as positive immunostaining.
The pattern of immunoexpression was classified as pre-
sent or absent. For semiquantitative analysis of immu-
nostaining, a score was attributed to each case according 
to the percentage of positive cells: 0 (no immunostai-
ning), 1 (1-25% immunostained cells), 2 (26-50% im-
munostained cells), and 3 (>51% immunostained cells). 
According to the manufacturers, the localization pattern 
of positive staining for each protein was: cytoplasmic 
for COX-2 and nuclear/cytoplasmic for CD1.
-Data analysis
Descriptive and quantitative data analysis was perfor-
med using the Statistical Package for the Social Sciences 
(SPSS) software, version 20.0 (SPSS Inc., Chicago, IL, 
USA). Pearson’s chi-square test was applied to determi-
ne differences in the expression of the proteins in COC. 
The level of significance was set at p≤0.05.
Results
A total of 6,250 oral and maxillofacial lesions were diag-
nosed during the study period; of these, 571 (9.1%) were 
odontogenic cysts and 286 (4.5%) were odontogenic tu-
mors. COC accounted for 0.32% (n = 20) of all cases.
All 20 cases were intraosseous lesions (Table 1). Of 
these, 11 samples represented excisional biopsies, and 
nine were incisional biopsies. There was a male predi-
lection (55%), with a male-to-female ratio of 1.2:1. Pa-
tient age ranged from 9 to 58 years (mean: 29.9 ± SD: 
18.1 years). With respect to anatomical location of the 
cysts, the mandible was the most affected site (55%), 
especially the posterior region. Eighteen (90%) patients 
were asymptomatic and two (10%) reported painful 
symptoms.
Eighteen records (90%) provided a radiographic des-
cription of the lesion. Fourteen (70%) had a radiolu-
cent aspect, three (15%) showed mixed aspects and one 
(5%) displayed a radiopaque aspect. Fifteen cases (75%) 
showed a unilocular aspect and five (25%) had no infor-
mation about the locularity of the lesion. Eleven cases 
(55%) exhibited well-defined radiographic aspects. The 
mean size of the lesion was approximately 3.2 ± SD: 
1.6 cm.
Morphological analysis showed a benign cystic pattern 
in all 20 cases. The cyst wall was lined with a thin ame-
loblastomatous epithelium whose basal layer consis-
ted of cubic or columnar cells. Superficially, the cells 
were loosely arranged, resembling the stellate reticulum 
of the enamel organ. In addition, variable numbers of 
slightly eosinophilic epithelial cells without a nucleus, 
called ghost cells, were observed, being occasionally 
calcified (Fig. 1). The presence of dysplastic dentin and 
the proliferation of odontogenic epithelium were noted 
Clinicopathological data n (%)
Total 20 (100)


















Not available 2 (10)
Size (cm), SD Mean: 3.2 ± 1.6
Range: 0.7-7.0
Table 1: Clinicopathological data of patients with calcifying odon-
togenic cysts.
cm, centimeters; SD: standard deviation.
Fig. 1: Histopathological features of a calcifying odontogenic cyst. 
Presence of ameloblastomatous epithelium lining the cystic cavity 
(H&E; Bars indicate 200µm).
inside adjacent tissue in half the cases. None of the ca-
ses analyzed was associated with odontogenic tumors or 
other cysts.
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Ten (50%) of the 20 cases studied exhibited a predomi-
nantly mononuclear inflammatory infiltrate. An inflam-
matory infiltrate was not evident in the two symptoma-
tic cases; however, these samples were from incisional 
biopsies. Both COCs were more than 4.0 cm in size. One 
case was located in the posterior mandible, with dura-
tion of symptoms of 7 months and the other was located 
in the anterior mandible with symptomatology persis-
ting for 12 months.
Immunohistochemical analysis was performed in 12 
cases but was not possible in 8 due to insufficient ma-
terial. In most cases (n = 5, 41.6%), the cysts showed 
immunoexpression (score 1) of COX-2 in cells of the in-
flammatory infiltrate adjacent to epithelial proliferation. 
However, immunostaining for this protein was negative 
or weak in the epithelial lining of the cystic cavity (Fig. 
2). Staining for CD1 was positive in cells of the basal 
and parabasal layers in 66.6% of cases (n = 8), all of 
them classified as score 1 (Fig. 3). There were no statis-
Fig. 2: Expression of COX-2 protein in a calcifying odontogenic cyst. (A) Note the immunostaining in the inflammatory cells 
adjacent to the epithelium lining the cystic cavity with weak immunoexpression (IHC; Bars indicate 500µm). (B) At a higher 
magnification, strong immunostaining was observed in inflammatory cells (IHC; Bars indicate 200µm).
Fig. 3: Expression of CD1 protein in a calcifying odontogenic cyst. 
Observe the nuclear and cytoplasmic immunoexpression in epithelial 
cells of the basal and parabasal layers of the epithelium lining the 
cystic cavity (IHC; Bars indicate 200µm).
tically significant differences in the expression of these 
proteins in COC (Table 2).
Discussion
Although no consensus exists regarding the classifica-
tion and terminology of COC, in 2017, the WHO defi-
ned COC as a benign cystic lesion of odontogenic origin 
that can be classified into two variants: intraosseous and 
extraosseous (4). However, Praetorius et al. (2) sugges-
ted to classify this lesion as a cyst or tumor (solid). Three 
different types can be found in the cystic variant: simple 
unicystic, unicystic odontoma-producing, and unicystic 
with ameloblastomatous proliferation.
It is pertinent to note that among the 6,250 diagnoses 
made at our oral pathology service over a period of 26 
years, 20 cases were diagnosed as COC. Our results co-
rroborate the findings of Galana-Alvarez et al. (14) who 
found 0.3% of lesions diagnosed as COC at oral patho-
logy laboratories. Consensus exists that COC is a rare le-
Scores COX-2 CD1 p-value*
Negative 6 (50%) 4 (33.3%)
Score 1 5 (41.6%) 8 (66.6%)
Score 2 1 (8.3%) 0 (0%) 0.63
Score 3 0 (0%) 0 (0%)
Total 12 (100%) 12 (100%) -
Table 2: Immunoexpression of COX-2 and CD1 in calcifying odon-
togenic cysts.
*Pearson’s Chi-square test.
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sion, accounting for 0.37 to 7% of all odontogenic cysts 
and tumors (6,7,15,16). In this respect, the prevalence 
of COC was 4.8% among 3,875 cases analyzed in the 
retrospective study of Mohajerani et al. (17).
In the study of Li and Yu (18), 69% of the 21 cases diag-
nosed as COC occurred in the maxilla and the anterior 
region was the most affected site (62.5%). In contrast, of 
the 26 cases of COC identified by Luo and Li (6) among 
1,309 odontogenic lesions, 17 involved the maxilla and 
nine the mandible. In the present study, a higher fre-
quency of COC was observed in the posterior mandible 
(55%). Information about the anatomical location of the 
lesion is of fundamental importance for the differential 
diagnosis since other odontogenic cysts and tumors, and 
even non-odontogenic cysts and bone diseases such as 
focal cemento-osseous dysplasia and osteosarcoma, can 
be found at this site (7).
Geographic variation in the incidence and age distribu-
tion of odontogenic cysts and tumors is an important 
factor that has been discussed in several studies. Since 
these cysts are often asymptomatic, patients are diagno-
sed late. According to Buchner et al. (5), in developing 
countries, the number of odontogenic cysts and tumors 
without a histopathological exam may cause the inciden-
ce of these entities to be underestimated. In the study of 
Avelar et al. (19), patients diagnosed with COC were in 
their second and third decade of life. This finding might 
be due to the geographic location and different ethnic 
groups on which the study was conducted. According to 
Luo and Li (6), COC occurs in a broad age range (3-78 
years). In the present study, the mean age of the patients 
was 29.9 years, a finding that agrees with the epidemio-
logical studies cited above.
da Silva et al. (20) found a female predilection of COC 
in the northeastern Brazilian population, while Fregnani 
et al. (21) suggested no predilection. However, a dis-
crete correlation with female gender is observed when 
COC involves the maxillary region. In contrast, a male 
predilection (55%) was observed in the present study. In 
addition, 18 (90%) of the 20 cases were asymptomatic, 
in agreement with the findings of Li and Yu (18) and da 
Silva et al. (7).
With respect to histological features, the 2017 WHO 
classification of odontogenic cysts describes the mor-
phological pattern of the two variants, extra- and in-
traosseous, to be the same. This pattern includes a cyst 
wall lined with ameloblastomatous epithelium and the 
formation of ghost cells that can calcify, as well as epi-
thelial proliferation in adjacent connective tissue and the 
presence of dysplastic dentin (4). Furthermore, some au-
thors already agree with this current classification and 
not with the 2005 classification that COC is indeed a 
neoplasm. Praetorius et al. (2) and Iida et al. (22) sug-
gested that the cystic (non-neoplastic) forms can be ei-
ther intra- or extraosseous, in which a well-defined cys-
tic lesion is found and consists of a fibrous capsule and 
odontogenic epithelial lining of 4 to 10 cells.
Within this context, analysis of the expression of pro-
teins in odontogenic cysts and tumors such as COC is 
important to understand the molecular mechanism asso-
ciated with the behavior of these lesions. The expres-
sion of COX-2 is induced by different stimuli such as 
inflammatory signs, cytokines, growth factors, hormo-
nes, and tumor promoters. In inflammatory conditions, 
this protein is able to metabolize prostaglandins (23). In 
a review of the expression of COX-2 in head and neck 
tumors, Mendes et al. (24) found that the levels of this 
protein increase in different tumors with aggressive be-
havior, but that the underlying mechanism is still unk-
nown.
In the present study, positive immunostaining (score 
1) for COX-2 protein was observed in 41.6% of cases 
(n = 5) in which an inflammatory infiltrate was present 
adjacent to the cystic proliferation, while immunostai-
ning was negative or weak in the cystic epithelium. We 
believe that a weak immunostaining in the epithelium 
in a few cases may be due to induction from inflam-
matory cells that are secreting COX-2. The presence of 
an inflammatory infiltrate in developmental odontogenic 
cysts can be attributed to local trauma, aspiration punc-
ture or a previous biopsy. These stimuli are interpreted 
as aggression by the immune system.
Seyedmajidi et al. (25) demonstrated expression of 
COX-2 in epithelial cells of odontogenic keratocysts 
and ameloblastomas. When compared to ameloblasto-
mas and odontogenic keratocysts, the absence of COX-
2 immunostaining in a large extent of the epithelium of 
COC suggests a non-neoplastic phenotype of this lesion, 
as evident in odontogenic tumors. Data on the expres-
sion of COX-2 in COC are still sparse. To our knowled-
ge, this is the first study demonstrating the expression of 
this protein in COC.
Few immunohistochemical studies in the literature have 
investigated the expression of cyclins in odontogenic 
cysts and tumors. In the present study, positive staining 
for CD1 was observed in 66.6% of COC cases (n = 8), 
all of them classified as score 1, characterizing low pro-
liferative activity (26). In contrast, de Vincent et al. (27) 
reported variability in the expression of CD1 in tumors 
and cystic lesions of odontogenic origin. The authors ob-
served diffuse nuclear expression in basal and parabasal 
cells of ameloblastomas and odontogenic keratocysts and 
low expression in dentigerous cysts. According to our re-
sults, the low expression of CD1 in COC may indicate a 
behavior of these cysts similar to that of a cystic lesion as 
proposed by the current classification, and not of a neo-
plasm, considering that cystic lesions are generally less 
aggressive and have a lower proliferative potential.
Fregnani et al. (21) found the Ki-67 immunoexpres-
sion indices to be correlated with epithelial prolifera-
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tion. The authors detected higher proliferative activity 
in the epithelium of COC when these cysts occurred in 
association with odontomas and peripheral lesions and 
concluded that immunohistochemical analysis may be 
useful to diagnose the variants of COC. However, in the 
present study, COC was not associated with odontogenic 
tumors.
Since this was a retrospective study analyzing biopsy 
records, we do not have data regarding follow-up and 
recurrence of lesions, a fact that represents a limitation 
of this study. Therefore, single or multicenter prospec-
tive studies of COC lesions are feasible and should be 
encouraged.
Conclusions
Calcifying odontogenic cysts are uncommon lesions, 
with a low prevalence among all odontogenic cysts. Im-
munohistochemical analysis suggested that COX-2 does 
not participate in lesion progression and expression of 
CD1 suggested a proliferative profile compatible with 
more indolent lesions. Finally, we suggest expanding the 
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